RAC 2.92% $1.94 race oncology ltd

Ann: Preclinical & Clinical Programs Update, page-14

  1. 4,840 Posts.
    lightbulb Created with Sketch. 1099
    At the end of the day although there are some delays they have continued to "communicate" in a timely manner.

    I know its a bit disappointing that all the news flow expected this Q hasn't been received but I think it was pretty obvious that was going to be the case as the days dwindled.

    A lot of companies would not have even communicated on the delays or provided new expected timelines but rather left investors in the dark wondering WTF is going on, therefore I'm glad to see RAC continuing to do the things that differentiate them from the pack in terms of communicating in a timely manner even when its not all great news.

    PS nice to see us back above $3 lets hope we can hold.

    Cheers
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.